According to Stratistics MRC, the Global Neurovascular Devices Market is accounted for $1.90 billion in 2017 and is expected to reach $4.35 billion by 2026 growing at a CAGR of 9.6% from 2017 to 2026. Some of the key factors influencing the market growth are favorable medical reimbursements, rising target patient population and enhanced effectiveness and better patient outcomes. Moreover, rising number of researches in neurovascular therapies and rising demand for minimally invasive procedures will provide ample opportunities for the growth of the market. However, commercialization across developing economies and lack of skilled neurosurgeons are hampering the market growth.
Neurological devices/Interventional neurology is the non-surgical specialty that uses minimally invasive, image guided techniques for the treatment of most complex and dangerous diseases of neck, brain, and spine. Neurovascular devices are extensively used for the treatment of neurovascular diseases like brain aneurysm, arteriovenous malformations (AVMs), and others. A variety of material such as nitinol, cobalt, platinum can be used in neurovascular devices to achieve the specialized characteristics for aneurysm repair and ischemic stroke prevention.
By Therapeutic Application, the Ischemic strokes segment is anticipated to grow during the forecast period due to growing patient pool suffering from ischemic stroke. Ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked by a blood clot. By geography, North America has the highest market growth during the forecast period due to high pervasiveness of brain aneurysms. In U.S, High prevalence of ischemic stroke and stenosis will influence the growth.
Some of the key players include Penumbra, Inc., Johnson & Johnson, Microport Scientific Corporation, Abbott Laboratories, Stryker Corporation, Medtronic PLC , Terumo Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Boston Scientific Corporation, LivaNova PLC, Kaneka Medix Corp, Integra Lifesciences, Asahi Intecc CO., LTD, and Integer Holdings Corporation.
Disease Pathologies Covered:
• Arteriovenous Malformation and Fistulas
• Ischemic Strokes
• Cerebral Aneurysms
• Stenosis
Processes Covered:
• Stenting technique
• Neurothrombectomy procedure
• Coiling procedure technique
• Cerebral angiography technique
• Flow disruption technique
Products Covered:
• Cerebral Balloon Angioplasty and Stenting Systems
• Support Devices
• Aneurysm Coiling & Embolization Devices
• Neurothrombectomy Devices
• Revascularization Devices
• Accessory Devices
• Other Products
Therapeutic Applications covered :
• Ischemic strokes
• Cerebral Artery Stenosis
• Brain Aneurysm
• Other
• Hemorrhagic Stroke
• Therapeutic Application
End User:
• Ambulatory Surgical Units
• Hospitals
• Clinics
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Neurovascular Devices Market, By Device
7.1. Neurovascular Devices Market, By Device Type, 2020-2027
7.1.1. Cerebral Embolization and Aneurysm Coiling Devices
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Cerebral Angioplasty and Stenting Systems
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Neurothrombectomy Devices
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Support Devices
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Neurovascular Devices Market, By Application
8.1. Neurovascular Devices Market, by Application, 2020-2027
8.1.1. Stroke
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Cerebral Artery
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Cerebral Aneurysm
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Neurovascular Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Device (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Device (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Device (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Device (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Device (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Device (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Device (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Device (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Device (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Device (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Device (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Device (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Device (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Device (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Device (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Device (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Device (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Device (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Device (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Device (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Device (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
Chapter 10. Company Profiles
10.1. Medtronic
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. MicroPort Scientific Corporation
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Penumbra, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Johnson & Johnson Services, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. MicroVention, Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Codman Neuro
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers